Transcriptomics market size was valued at $5,790.51 million in 2020, and is estimated to reach $11,397.08 million by 2030, growing at a CAGR of 7.0% from 2021 to 2030. Transcriptomics is the study of transcriptome, a complete set of RNA, which is known as expression profiling. Transcriptomics encompasses everything related to RNAs. It includes their expression levels, functions, locations, and degradation. Transcriptome analysis enabled the study of how gene expression changes in different organisms and has been instrumental in the understanding of human disease.
𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :
The global hypodermic needles market report includes study of major market players including Agilent Technologies Inc., F-Hoffmann La-Roche, Bio-Rad Laboratories, General Electric Company, Fluidigm Corporation, Merck & Co. Inc., Illuminia Inc., QiagenInc, Promega Corporation, and ThermoFisherScientific.
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/2595
- The Covid-19 pandemic had a positive impact on the market due to increase in production of vaccines and rise in investment to study immune response in Covid-19 infected patients.
- Increase in number of product approvals and new innovations by key players supplemented the market growth yet more.
The global transcriptomics market is segmented on the basis of type, technology, applications, and region. By application type, the diagnostics and disease profiling segment is projected to manifest the highest CAGR of 7.5% from 2021 to 2030. However, the drug discovery segment held the largest share in 2020, accounting for more than three-fifths of the global transcriptomics market.
By end user, the pharmaceutical & biotechnology companies segment is expected to register the highest CAGR of 7.8% from 2021 to 2030, due to surge in variety of applications in diagnostics and diseases analysis. However, the government institutes and academic centers segment held the lion’s share in 2020, accounting for around half of the global transcriptomics market, owing to surge in diagnosis of diseases.
𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 https://www.alliedmarketresearch.com/purchase-enquiry/2595
By region, the global transcriptomics market across North America dominated in 2020, accounting for more than two-fifths of the market, owing to robust infrastructure provided for research activities and presence of key players across North America. However, the market across Asia-Pacific is anticipated to showcase the highest CAGR of 8.7% during the forecast period, owing to surge in use of transcriptomics for drug discovery, R&D activities for new product launch, and surge in investment in the healthcare sector.
𝐊𝐄𝐘 𝐅𝐈𝐍𝐃𝐈𝐍𝐆𝐒 𝐎𝐅 𝐓𝐇𝐄 𝐒𝐓𝐔𝐃𝐘
- By type, the consumables segment was the highest contributor to the market in 2020.
- By technology, the q PCR segment was the highest contributor to the market in 2020.
- On the basis ofapplication type, the drug discovery segment dominated the market in 2020, and is expected to continue this trend during the forecast period.
- Region wise, North America garnered the largest revenue share in 2020, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
5933 NE Win Sivers Drive
205, Portland, OR 97220
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060